Abstract
I. Introduction
Diabetic men have significantly lower concentration of free and total testosterone than non-diabetic men 1, 2 . Testosterone levels are not only lower in menwith type 2 DM, but also that the risk of developing type 2 DM is increased in men with low testosterone levels 3, 4 .Hypogonadism has also been reported in diabetic men.Massachusetts Male Aging study and others prospectively suggest that low concentration of serum testosterone had been related to the development of insulin resistance ,which is an important cause for inducing type 2 diabetes mellitus, hyperglycemia, dyslipidemia, and coronary artery diseases 5 . Some authors suggest that, at physiological levels, testosterone has a role in maintaining normal insulin sensitivity in men, an effect that is lost at low or high concentrations 6 . Other studies have shown that administration of testosterone to hypogonadal middle-aged men improves insulin sensitivity and glucose homeostasis 7, 8 . The prevalence rate ofsymptomatic hypogonadism in men with type 2 DM is high and documented rates range from 20-64% with higher prevalence rates reported in the elderly 9 . Thus the purpose of the present study was to evaluate the relationship between type 2 DM and serum testosterone,LH and FSH level and to evaluate its association with other conventional risk factors for diabetes mellitus. 
II. Aims And Objectives

Exclusion criteria
Patients taking drugs which are known to interfere with serum testosterone levels for example, glucocorticoids, hormone replacement therapy, ketoconazole, opiods, methadone, heroin and marijuana.,Patients with features associated with congenital GnRH deficiency (midline facial defects, synkinesis or a family history of GnRH deficiency or anosmia).History oftumor, exposure to radiation, history of head trauma, spinal cord injuries, history of pelvic trauma and surgery.Any disease other than diabetes known to cause autonomic dysfunction.Any other chronic disease such as human immunodeficiency virus (HIV), end-stage renal disease, cirrhosis of liver and psychiatric disease.etc were excluded from the study All 80 male patients with type 2 diabetes mellitus and 40 controls after informed consent, were studied based on the detailed history, anthropometric measurements, relevant blood investigations, HbA1C, ECG changes and estimation of serum total testosterone and LH and FSH. Estimation of cardiac markers was done wherever required. TT was measured by fully automated bi directionally interfaced chemiluminescentimmunoassay(CLIA) And FT was measured by radio immune assay(RIA), Normal levels of TT were taken as 300-1000ng/dl and normal levels of FT as 9-40pg/ml. In all men LH/FSH were measured by chemiluminescentimmunoassay(CLIA). Normal level of LH were taken as 2.0 -12.0 miu/ml Normal level of FSH were taken as 1.0-12.0 miu/ml. Stastistical analysis the data are presented as means ±standard deviation(SD). For different qualitative parameters mean and standard deviation calculated. To compare the means between two groups, student unpaired 't' test is used. Level of significance is taken as p<0.05. Chi square test is used to find the association between two qualitative variables.
III. Results
Mean of age in diabetic patient was 48.32 ± 8.20 years and in non-diabetic 47.02±9.42 years(p value=0.042) . (table 1) Fasting blood sugar in diabetic patients(134.53±15.5) was significantly higher in comparison to nondiabetic controls(110±6.81) (p value <0.001) (table 1).
Mean free testosterone concentrations in diabetic men(7.65± 2.14) were significantly lower in comparison tonon-diabetic men(11.17±2.30)(p<0.001). (table 1) .
Mean Total testosterone concentrations in diabetic men(300.72±33.14) were significantly lower in comparison to non-diabetic men(383.81±57.63)(p<0.001). (table 1) . But there was no significant difference between two groups in the means of LH and FSH. (Table 1 ) The serum total testosterone was decreased in 23 cases (28.75%) and 8 controls (25%), and the difference was statistically significant. The serum free testosterone was decreased in 46 cases (57.5%) and 8 controls (25%), and the difference was statistically significant. The serum LH level was decreased in 10 cases(12.5%) and 04 controls(10%),and the difference was statistically not significant. The serum FSH level was decreased in 09 cases(11.25%) and 03 controls(7.5%), and the difference was statistically not significant. In case group 28 patients (35%) had DM2 for >5 yrs, And 22 patients (27.5%) with duration between 1-5 yrs. 30 patients (37.5%) had DM2 <1yr. (newly diagnosed cases of DM2) Among the patient with DM 2 for >5yrs, 12 (42.85%) and 18(64.28%) had low levels of serum total and free testosterone respectively. And 03(10.71%) had low levels of both LH and FSH hormones. these difference were statistically significant only for total testosterone. In case group serum total testosterone was decreased most in 3 (37.5%) and 4 (50%) patients with HbA1c <6.5 and >10.5 respectively. Serum free testosterone was decreased most in 30 (63.82%) and 06 (75%) patients with HbA1c between 6.5-8.4 and >10.5 respectively. but these differences were statistically not significant.
IV. Discussion
Diabetes mellitus is most common endocrine disorder which involves multiple organs and leads to significant morbidity and mortality due to accompanying complications. Erectile dysfunction, reduced libido, orgasmic dysfunction, and retrograde ejaculation are established complications found with variable prevalence in men with diabetes. Various studies have shown that patients with type 2 diabetes have frequent occurrence of hypogonadism as reflected by their low plasma concentration of free testosterone. (Tomar et al, 2006) 12 . Coronary artery disease (CAD) is a major cause of mortality and morbidity in developed world, and in developing countries, the incidence is rising. Atherosclerosis is the major cause of CAD. CAD manifests as acute coronary syndrome (ACS) and stable angina.
Men are more than twice as likely as women to die from coronary heart disease, and this ratio is consistent in all population and is not related to differences in risk factors (British Heart Foundation Statistics Database, 1998). Low testosterone level are associated with CAD 15 and low serum 14 . Furthermore, low testosterone levels are associated with several risk factors for the development ofCAD including systolic and diastolic hypertension, adverse lipid profile, and high levels of fibrinogen and procoagulable factors 15 .
In present study out of 26 (32.5%) of obese patients with DM2, 16(61.51%) had low levels of total testosterone and 20(76.9%) had low serum free testosterone. Whereas Dhindsaet al 16 (2010) reported prevalence of low testosterone in obese diabetics to be 50%. The phenomenon of testosterone deficiency in diabetic patients with higher BMI could be due to increase in adipose tissues mass which results in increased aromatase activity, leading to enhanced conversion of testosterone in to estradiol which further suppresses hypothalamic-pituitarytesticular axis and decreases testosterone secretion (Giagulli et al 17 , 1994) . Adipose tissue,which is considered as an endocrine organ and produces a host of hormones and cytokines, may modulate insulin action and regulate leydig cell function. Leptin production is tightly coupled to insulin resistance and may play a key role in steroid biogenesis and reduced testosterone levels. Leptin levels have been shown to be inversely correlated with serum testosterone levels (Haffner et al, 1997; Luukkaa et al, 1998) 18, 19 , and increased circulating leptin may be involved in the pathogenesis of leydig cell dysfunction (Isidori et al 20 , 1999 ). Other possible mechanism involved in pathogenesis of obesity related low testosterone is insulin resistance (Dhindsaet al 16 2010 ). In present study, 23 out of 80 type 2 diabetes mellitus patients (28.75%) and 8 out of 40 controls (25%) had low level of total testosterone in serum, whereas 46 out of 80 diabetes mellitus patients (57.5%) and 8 out of 40 controls (25%) had low levels of free testosterone. And 10 out of 80 type 2 diabetes mellitus patients (12.5%) and 04out of 40 controls (10%) had low level of Serum LH in serum, whereas 09 out of 80 diabetes mellitus patients (11.25%) and 03 out of 40 controls (7.5%) had low levels of Serum FSH. Mean serum total testosterone in cases was 300.72±33.14 and in control group was 383.81±57.63.The difference was statistically significant.
Mean serum free testosterone in cases was 7.65±2.04 and in control group was 11.17±2.30. The difference was statistically significant. Mean serum LH level in cases was 5.53 and in control group was 6.22. The difference was statistically not significant.
Mean serum FSH level in cases was 5.82 and in control group was 6.49. The difference was statistically not significant.
In the study by Ernani et al 21 2005, low levels of serum total testosterone was found in patients with diabetes mellitus (34%) when compared to healthy control subjects (23%).
In the study by Kapoor et al 22 2007 , low levels of total testosterone was found in (25%) of patients with diabetes mellitus.
In the study by Ernaniet al 21 2005 level of free testosterone was decreased in 46% of diabetics as compared to 24% in non-diabetics
In present study, prevalence of high cholesterol (>200 mg/dl) in diabetic patients was 18 out of 80(22.5%), of which all 18 patients (100%) had low serum free testosterone level. Prevalence of low serum free testosterone among patients with high serum cholesterol in type 2 diabetes was 100% while 66.6% of controls had high serum cholesterol with low free testosterone.
In the present study, the mean total cholesterol in cases was 201.95±26.96mg/dl and in controls 188.12±17.34 mg/dl. The total cholesterol was higher in cases than controls and the difference was statistically significant.
In GMC Rosanoet al 23 2007 study, total cholesterol was 247±25 mg/dl. In Majon Muller et al 24 2003 study, total cholesterol was 226.6±1.11 mg/dl and is comparable to our study.
The result of the present study and previous studies is in accordance with cardiovascular risk attributed to total cholesterol.
In present study, occurrence of low HDL ( <40 mg/dl) in diabetic patients was 55 out of 80( 68.75%), of which 32( 85.18%) had low serum free testosterone level.
Prevalence of low HDL (<40 mg/dl) in diabetic patients with low testosterone was 7 out of 55 (58.18%) in present study whereas Mathis et al 25 (2008) reported low testosterone levels in 28% cases. The mean HDL cholesterol level in cases was 36.16±5.62 mg/dl and controls was 45.80±7.20 mg/dl. The mean HDL-C level in Majon Muller et al 24 2003 study was 51.81±0.33 mg/dl. Then HDL-C level in KT Khawet al 26 2007 study was 47.95±0.32 mg/dl. The lower level of HDL-C in case and control in our study is in accordance to the prevalent lipid status of South Asian population.
In the present study prevalence of raised LDL-C (>100) levels in DM2 patients was 38.75% (31 out of 80) while in controls was 45 %( 18 out of 40).
Out of 31 cases, 23(74.1%) had low level of free testosterone and out of 18 controls, 4 (22.2%) had low level of free testosterone. The mean LDL-cholesterol level in the present study was 114.63±26.79 mg/dl in cases and 102.97±20.03 mg/dl in controls, and the difference was statistically significant.
In Majon Muller et al 24 2003 study, the mean LDL-C level was 150.42±0.98 mg/dl. In present study prevalence of high triglyceride (<150mg/dl) in diabetic patients was 53 out of 80 (66.25%) of which 36 (78.26%) had low serum free testosterone level.
Prevalence of high triglyceride (>150 mg/dl) in control group was 10 out of 40 (25%) of which 3 (37.5%) had low free testosterone level.
The mean triglyceride level in the cases was 153.57±12.41and in controls 124.45±31.15, the difference was not statistically significant.
Prevalence of elevated triglycerides (>150 mg/dl) in diabetic patients with low free testosterone was 36 out of 53(67.9%)in present study whereas Mathis et al 25 (2008) reported that prevalence of elevated triglyceride in diabetic patients with low testosterone levels was 45% in their study of 649 patients.
These findings indicate higher incidence of dyslipidemia in patients with low serum free testosterone. Low free testosterone was more commonly found in patients with high serum cholesterol (100% vs 16.6%), low HDL-C level (74.17% vs. 22.2%) and high serum triglyceride (68.755% vs 58.18%) as compared to control group. Difference was statistically significant.
V. conclusions
The present study showed that serum free and total testosterone is lower intype 2 diabetic patients in compared with non-diabetic men.
This study shows that low serum free testosterone in diabetes correlates positively with low HDL, , high serum triglyceride, increase total cholesterol and LDL levels. Low serum free testosterone is also significantly associated with increased risk for coronary artery disease in diabetic patients.
The results also showed that there was a non-significant negative relationship between serum free/totaltestosterone ANDHbA1c and Duration of diabetes.it may be because of small sample size and shorter duration of study,for these larger studies are required. However there were no significant differences between LH and FSH level in diabetic men compared to healthy controls.
Thus it is important to evaluate cases of diabetes with respect to free testosterone level for early detection and management of hypogonadism for better sexual and mental function of such patients.
